Share This Article
Why Biospecimen Procurement Shouldn’t Be a “One-Click” Process
At ABS Bio, our mission is simple: make it easy to get the high-quality human biospecimens you need to advance your research.
At first glance, it might seem like a web store or online marketplace could accomplish this. After all, similar platforms already exist. Wouldn’t that make the process faster and cheaper?
In theory—yes. But in practice, human biospecimens are not commodities. Unlike computers or lab equipment, each sample represents a unique human donor, with biological and contextual variables that directly affect your data integrity and study outcomes.
Why “One-Size-Fits-All” Doesn’t Work for Biospecimens
When you buy a laptop online, you configure your system from fixed variables, add it to your cart, pay and then receive exactly what you expect.
Biospecimens don’t work that way.
Each donor differs by:
- Demographics (age, sex, race)
- Medical and treatment history
- Medications and comorbidities
- Collection methods and site practices
These differences matter. A variable such as collection timing, preservation technique, or pathology reporting can make or break the suitability of a specimen for your research.
Even cost structures vary between collection sites—so any “flat” pricing model would have to be artificially inflated to cover every scenario.
The Variables That Matter
When sourcing biospecimens, experienced researchers know that every project has its own parameters.
Here are just some of the factors that must be considered:
| Category | Example Variables |
|---|---|
| Ethical & Regulatory | Informed consent scope, IRB review, country-specific regulations |
| Donor Profile | Age, sex, race, diagnosis, treatment history |
| Collection & Preservation | Time to preservation, fixatives, storage conditions |
| Pathology & Data | Full or partial pathology reports, histology, gene expression data |
| Medical & Medication History | Specific conditions, drug exposure, duration |
| Sample Specifications | Tumor percentage, necrosis, preservation type, sample size |
| Quality Control | RIN values, histology verification, IHC testing |
| Pricing | Customized for prospective or retrospective collections |
| Logistics & Shipping | How much do you need, when do you need it, temperature excursions during shipping, communication about package progress |
Each of these elements influences sample quality, study relevance, and reproducibility.
The Case for a Consultative Approach
Rather than offering a “shopping cart” experience, ABS Bio takes a collaborative, consultative approach.
Our biospecimen experts work directly with you to:
- Define your scientific and budgetary requirements
- Identify suitable collection sites and ethical parameters
- Customize collection and processing methods
- Ensure that quality control measures align with your study’s goals
- Deliver samples that are truly fit for purpose and on-time
This process doesn’t slow you down—it prevents wasted time, effort, and expense on unsuitable material.
Avoiding the Pitfalls of Commoditization
Marketplaces encourage “good enough” thinking.
They make it easy to overlook variables that could impact your findings—or miss opportunities to design collections that support both your current study and future research.
By contrast, our model promotes:
- Creative problem-solving for challenging requests
- Access to a wide network of qualified collection sites
- Transparency and flexibility around pricing, QC, and turnaround time
Our Commitment to You
ABS Bio exists to provide the right samples, not just available samples.
We’ll work with you to clarify your needs, source from the best-suited sites, and ensure that every specimen supports the integrity of your research.
That’s why we continue to focus on customizable, scientist-driven solutions—not a one-click marketplace.
The fastest way to get what you truly need? Talk with our team.
We’ll make sure your biospecimen strategy supports your science today—and sets you up for success tomorrow.
HARMINDER SINGH, M.D.
Business Development Director, ABS Bio
15+ years in life sciences
Biospecimen operations expert
Precision medicine research
Harminder Singh, M.D. is Business Development Director at ABS Bio. He joined ABS Bio from Cureline, where he was instrumental in leading biospecimen operations. He brings more than 15 years of experience in the life sciences industry and is a recognized expert in human biospecimen sourcing, management, and global clinical research. Dr. Singh is actively engaged in designing and executing research projects involving human biospecimens to help develop precision medicine therapies. He has a strong track record of building and maintaining long-term partnerships with clinical networks and pharmaceutical/biotechnology clients.
